Fool - Investing News
24 Jun 2026, 20:54 UTC · 11w ago
Verdict
Headline leans bullish. We score KMTS +0.60 across three claims.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.60strongly bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Kestra Medical Technologies raised its fiscal 2026 revenue guidance to $93 million, implying 55% annual growth.
More positive than 91% of claims this week
Kestra reported quarterly revenue of $24.6 million, a 63% increase year-over-year, with gross margins expanding to 52.6% from 43.4%.
Continue reading
5 related stories
More positive than 76% of ticker scores this week
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 85% of claims this week
Brian Daniel Webster sold 15,000 common shares of Kestra Medical Technologies at a weighted average price of $20.81.
More negative than 62% of claims this week
Which stocks this story touches
More positive than 76% of ticker scores this week
The company reported strong 63% year-over-year revenue growth, expanding gross margins, and raised its 2026 revenue guidance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
11h ago
+13.9%
Price agrees with the score
$25.14 vs $22.08 close before publication (Jun 24) · not market-adjusted
KMTS chart →
